Literature DB >> 20856737

Safe handling of parenteral cytotoxics: recommendations for ontario.

Esther Green1, Mary Johnston, Maureen Trudeau, Lisa Schwartz, Susan Poirier, Gail Macartney, Deborah Milliken.   

Abstract

In caring for patients with cancer, health care workers may be exposed to cytotoxic agents. Recommendations are needed to mitigate potential risks for cancer and adverse reproductive outcomes associated with exposure.

Entities:  

Year:  2009        PMID： 20856737      PMCID： PMC2790670          DOI： 10.1200/JOP.091014

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


  19 in total

1.  Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States.

Authors:  T H Connor; R W Anderson; P J Sessink; L Broadfield; L A Power
Journal:  Am J Health Syst Pharm       Date:  1999-07-15       Impact factor: 2.637

Review 2.  ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs.

Authors: 
Journal:  Am J Hosp Pharm       Date:  1990-05

3.  Guidelines for handling parenteral antineoplastics. Council on Scientific Affairs.

Authors: 
Journal:  JAMA       Date:  1985-03-15       Impact factor: 56.272

4.  The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation.

Authors:  G P Browman; M N Levine; E A Mohide; R S Hayward; K I Pritchard; A Gafni; A Laupacis
Journal:  J Clin Oncol       Date:  1995-02       Impact factor: 44.544

5.  Mutagenicity in urine of nurses handling cytostatic drugs.

Authors:  K Falck; P Gröhn; M Sorsa; H Vainio; E Heinonen; L R Holsti
Journal:  Lancet       Date:  1979-06-09       Impact factor: 79.321

6.  Airborne drug levels in a laminar-flow hood.

Authors:  M L Kleinberg; M J Quinn
Journal:  Am J Hosp Pharm       Date:  1981-09

Review 7.  Second cancers after breast cancer treatment.

Authors:  Sister Mary Andrew Matesich; Charles L Shapiro
Journal:  Semin Oncol       Date:  2003-12       Impact factor: 4.929

8.  Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients.

Authors:  Marc André; Nicolas Mounier; Xavier Leleu; Anne Sonet; Pauline Brice; Michel Henry-Amar; Hervé Tilly; Bertrand Coiffier; André Bosly; Pierre Morel; Corinne Haioun; Philippe Gaulard; Felix Reyes; Christian Gisselbrecht
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

9.  Exposure of hospital workers to airborne antineoplastic agents.

Authors:  A deWerk Neal; R A Wadden; W L Chiou
Journal:  Am J Hosp Pharm       Date:  1983-04

10.  Second malignancies after chemotherapy and radiotherapy for Hodgkin disease.

Authors:  Gregory M Chronowski; Richard B Wilder; Larry B Levy; Edward N Atkinson; Chul S Ha; Fredrick B Hagemeister; Ibrahim Barista; Maria A Rodriguez; Andreas H Sarris; Mark A Hess; Fernando Cabanillas; James D Cox
Journal:  Am J Clin Oncol       Date:  2004-02       Impact factor: 2.339
View more
  1 in total

1.  [Not Available].

Authors:  Alexia Janes; Cécile Bérard; Jean-François Bussières
Journal:  Can J Hosp Pharm       Date:  2016 Jan-Feb
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.